Molecular Methodologies & Technologies

Thursday, November 1, 2018
SCIENTIFIC INFORMATION
7:00am - 8:00am	EARLY BIRD SESSIONS Personalized Genomics: Advancing Continuity in Research to Clinical Care Vincent Magrini, PhD, Institute for Genomic Medicine (IGM) at Nationwide Children's Hospital, Columbus, OH, USA Catherine E. Cottrell PhD PhD, Nationwide Children's Hospital, Columbus, OH, USA Lab of the Future: Cool Toys for the Diagnosis of Infectious Diseases Validation of the Karius Microbial Cell-free DNA Sequencing Test for Infectious Disease Timothy A. Blauwkamp, PhD, Karius, Inc., Redwood City, CA, USA A Smart Diagnostic: Technology that Learned to Identify and Count Individual Bacteria in Blood Stephanie I. Fraley, PhD, University of California, San Diego, CA, USA
1:00pm - 2:30pm	CONCURRENT WORKSHOPS Molecular Tumor Board Elizabeth Swisher, MD, University of Washington, Seattle, WA, USA Stephen Lincoln, Invitae, San Francisco, CA, USA Eric H. Bernicker, MD, Houston Methodist Hospital, Houston, TX, USA Valentina Nardi, Massachusetts General Hospital, Boston, MA, USA Jonathan A. Nowak, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA Angela Jacobson, MS, University of Washington, Seattle, WA, USA

Friday, November 2, 2018
SCIENTIFIC INFORMATION
7:00am - 8:00am	EARLY BIRD SESSIONS Keys to Publishing in Scientific Journals Barbara A. Zehnbauer, PhD, Emory University School of Medicine, Atlanta, GA, USA
3:30pm - 5:00pm	CONCURRENT SYMPOSIA Utilization of CRISPR/Cas Technique as Anti-Viral Therapeutic Agent and as an Adaptive Immune Modulator in DNA Editing and RNA Targeting CRISPR/Cas9 Targeting and Inactivation of Viral DNA Genomes Bryan R. Cullen, PhD, Duke University Medical Center, Durham, NC, USA Programmable RNA-targeting CRISPR-Cas Enzymes for RNA Detection and Therapeutics Mitchell R. O'Connell, PhD, University of Rochester, Rochester, NY, USA Clinical Advances in NGS Robert L. Nussbaum, MD, Invitae Corporation, San Francisco, CA, USA Wayne W. Grody, MD, PhD, University of California, Los Angeles, CA, USA Insilico Sequencing Data and Tools: Current and Future Applications in Clinical Practice "In Silico" Proficiency Testing John D. Pfeifer, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA In Silico Proficiency Testing for Clinical Next Generation Sequencing Karl V. Voelkerding, MD, University of Utah School of Medicine, Salt Lake City, UT, USA

Saturday, November 3, 2018
SCIENTIFIC INFORMATION
7:00am - 8:00am	EARLY BIRD SESSIONS AMP Guidance for Non-standard or Emerging NGS Applications: Liquid Biopsy Christina Lockwood, PhD, University of Washington, Seattle, WA, USA Christopher D. Gocke, MD, Johns Hopkins University, Baltimore, MD, USA Platform Presentation of Selected Technical Topics Abstracts TT074 - Multi-Patient Longitudinal Monitoring of Cancer Mutations from Circulating DNA of Using Personalized Single Color Digital PCR Assays Christina M. Bouwens, Stanford University, Stanford, CA, USA TT059 - Cell-free DNA Allograft Rejection Monitoring Using Low-coverage Whole Genome Sequencing Niklas Krumm, MD, PhD, University of Washington, Seattle, WA, USA TT070 - Universal Design and Rapid PCR for Genotyping by High Resolution Melting Jessica Houskeeper, MRes , University of Utah, Salt Lake City, UT, USA TT046 - The NIH Genetic Testing Registry (GTR): Test Methodologies as a Sensor of the Precision Medicine Environment Adriana Malheiro, MS, National Center for Biotechnology Information, NIH, Bethesda, MD, USA
10:45am - 12:15pm	WORKSHOPS Clinical Implementation of Liquid Biopsy for Cancer Patients Clinical Applications of Digital PCR Maria Arcila, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA Liquid Biopsy for Solid Tumors: Promises and Perils Mark Routbort, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, USA
1:30pm - 3:00pm	CONCURRENT SYMPOSIA Metagenomic Characterization of Molecular Scientists Christopher E. Mason, PhD, Weill Cornell Medicine, New York, NY, USA